Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.3520
+0.0320 (10.00%)
Apr 8, 2026, 2:33 PM AEST
Dimerix Market Cap
Dimerix has a market cap or net worth of 192.13 million as of April 7, 2026. Its market cap has decreased by -30.57% in one year.
Market Cap
192.13M
Enterprise Value
153.67M
Revenue
7.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 192.13M, an increase of 1,351.50%. That is a compound annual growth rate of 28.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 192.13M | -41.82% |
| Dec 31, 2025 | 330.22M | 74.10% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 220.32M |
| Orthocell | 218.40M |
| Starpharma Holdings | 210.07M |
| Actinogen Medical | 132.89M |
| Recce Pharmaceuticals | 131.58M |
| Amplia Therapeutics | 123.14M |
| Paradigm Biopharmaceuticals | 115.68M |
| Island Pharmaceuticals | 107.89M |